0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Prostate Cancer Drugs Market Report 2025 - Product Thumbnail Image

Prostate Cancer Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Prostate Cancer Therapeutics Global Market Report 2025 - Product Thumbnail Image

Prostate Cancer Therapeutics Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$5,850USDGBP
From
EUR$4,850USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$2,999USDGBP
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more